Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential

Nipah virus (NiV) disease is a bat-borne zoonosis responsible for outbreaks with high lethality and is a priority for vaccine development. With funding from the Coalition of Epidemic Preparedness Innovations (CEPI), we are developing a chimeric vaccine (PHV02) composed of recombinant vesicular stoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Monath, Thomas P., Nichols, Richard, Tussey, Lynda, Scappaticci, Kelly, Pullano, Thaddeus G., Whiteman, Mary D., Vasilakis, Nikos, Rossi, Shannan L., Campos, Rafael Kroon, Azar, Sasha R., Spratt, Heidi M., Seaton, Brent L., Archambault, W. Tad, Costecalde, Yanina V., Moore, Evan H., Hawks, Roger J., Fusco, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269911/
https://www.ncbi.nlm.nih.gov/pubmed/35759511
http://dx.doi.org/10.1371/journal.ppat.1010658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269911/
https://www.ncbi.nlm.nih.gov/pubmed/35759511
http://dx.doi.org/10.1371/journal.ppat.1010658

Ejemplares similares